3. Preop period
• Preoperative management
Myasthenia gravis causes weakness of voluntary muscles, including those involved in breathing, so patients are at risk of developing postoperative respiratory failure. If bulbar palsy is present, they may also develop aspiration pneumonia. Medical treatment is associated with its own complications. Anticholinesterase treatment increases vagal tone, enhances oral secretion, and potentiates laryngeal spasms. Prolonged steroid use can result in electrolyte imbalance and increased susceptibility to infection.
Before elective surgery:
- distribution and severity of muscle weakness should be carefully assessed;
- respiratory function and nutritional status should be documented and medical treatment optimized.
Patients with severe weakness may require preoperative plasmapheresis, together with steroid and anticholinesterase therapy.
Admission to the intensive care unit for ventilatory support is indicated for patients with respiratory failure, but it is not necessary to wait until the patient is extubated before surgery can proceed.
Intravenous immunoglobulin is an alternative to plasmapheresis, but there is no clear evidence that one is better than the other.
Patients should be warned of the possibility of postoperative ventilation.
Premedication is appropriate, but respiratory depressant drugs are avoided.
“Stress” doses of steroids may be required.
General anesthesia with a left-sided double-lumen endobronchial tube is used and confirmed with a fiberoptic bronchoscope. Selective one-lung ventilation to the left lung is required to facilitate the operation (Yim et al., 1999). Hypoxemia during one-lung ventilation is usually caused by shunting of blood. In case of hypoxemia, the position of the double-lumen endobronchial tube and hemodynamic stability should be confirmed. A low level of continuous positive airway pressure (CPAP) applied to the collapsed right lung may improve saturation. Applying positive end expiratory pressure (PEEP) to the ventilated lung can also raise oxygen saturation during one-lung ventilation (Low, 2000).
Patients with myasthenia gravis are usually more susceptible to the neuromuscular blocking effect of volatile anesthetics so nondepolarizing muscle relaxants are usually not required (El-Dawlatly and Ashour, 1994).
Patients with MG are usually also very sensitive to nondepolarizing muscle relaxants (Smith et al., 1989; Nilsson and Meretoja, 1990).
If muscle relaxation is necessary during the course of anesthesia, a reduced dose of an intermediate-acting nondepolarizing muscle relaxant should be used followed by a carefully titrated intravenous infusion. Monitoring neuromuscular transmission is mandatory to adjust the dose of muscle relaxant used and to ensure complete reversal of neuromuscular blockade after surgery (Baraka, 1992).
• Continuous monitoring
- electrocardiogram, non-invasive blood pressure, pulse oximetry;
- end-tidal CO2, airway pressure, ventilatory volume, inspired oxygen, and neuromuscular transmission.
An arterial line and a central venous catheter for invasive pressure monitoring may be required for coexisting medical conditions.
|